As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

Some antibiotics, antivirals, vaccinations and anti-inflammatory medications are linked to a reduced risk of dementia, a ...

A little-known arm of the National Institutes of Health (NIH) has directed over $1 billion into “sexual and gender minority” ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

On January 15, 2025, the United States Food and Drug Administration (FDA) made a landmark decision to ban the use of Red Dye ...

The research over the next two years will be used to help agencies across the country best intervene in the ongoing substance abuse crisis.

Debate over the risks and benefits of the population weight loss drugs like Ozempic, Wegovy, and Zepbound finally came to an ...

About half of U.S. adults have high blood pressure, a major risk for heart attacks, strokes, kidney failure, even dementia.

Researchers took drugs currently used to treat type 2 diabetes and obesity and looked into how they affect 175 conditions.